Keizer, OR, United States of America

Tove C Bolken

USPTO Granted Patents = 24 

 

 

Average Co-Inventor Count = 4.5

ph-index = 2

Forward Citations = 31(Granted Patents)


Location History:

  • Jefferson, OR (US) (2006)
  • N. Keizer, OR (US) (2014 - 2015)
  • Keizer, OR (US) (2011 - 2020)

Company Filing History:


Years Active: 2006-2020

Loading Chart...
Loading Chart...
Loading Chart...
24 patents (USPTO):Explore Patents

Title: Tove C. Bolken: Pioneering Innovator in Pharmaceuticals

Introduction:

Meet Tove C. Bolken, a renowned inventor based in Keizer, Oregon, with an impressive track record of 24 patents to his name. Bolken is a visionary in the field of pharmaceuticals, consistently pushing the boundaries of innovation in medicine.

Latest Patents:

Bolken's latest groundbreaking patents include the development of ST-246 liquid formulations and methods. These patents showcase his ingenuity in creating novel liquid formulations for solubilizing poorly soluble ST-246 in cyclodextrins, along with a revolutionary process for manufacturing these formulations.

Career Highlights:

Throughout his career, Bolken has made significant contributions to the pharmaceutical industry. Notably, he has lent his expertise to companies such as Siga Technologies Inc. and Kineta Four, LLC, where his innovative work has left a lasting impact on the field.

Collaborations:

Bolken has had the privilege of collaborating with esteemed professionals in the industry, including Dennis E. Hruby and Dongcheng Dai. Together, they have worked on pioneering projects that have reshaped the landscape of pharmaceutical innovation.

Conclusion:

In conclusion, Tove C. Bolken stands as a trailblazer in the world of pharmaceutical inventions, with a remarkable portfolio of patents that reflect his unwavering commitment to driving innovation forward. His groundbreaking work continues to inspire and shape the future of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…